US equities
|
MU
$1,015.75
▼-2.85%
NVDA
$238.10
▼-0.48%
AMD
$641.55
▼-1.21%
INTC
$112.69
▲+0.17%
SPCX
$169.66
▼-1.31%
SNDK
$1,629.62
▼-1.86%
AAPL
$334.07
▲+0.13%
MRVL
$278.51
▼-2.96%
MU
$1,015.75
▼-2.85%
NVDA
$238.10
▼-0.48%
AMD
$641.55
▼-1.21%
INTC
$112.69
▲+0.17%
SPCX
$169.66
▼-1.31%
SNDK
$1,629.62
▼-1.86%
AAPL
$334.07
▲+0.13%
MRVL
$278.51
▼-2.96%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
BioRestorative Therapies, Inc. - Common Stock
(NQ:
BRTX
)
2.300
+0.030 (+1.32%)
Delayed Quote
Updated: 9:30 AM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioRestorative Therapies, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session
↗
September 29, 2022
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares jumped 52% to $2.1325 after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
↗
September 28, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 28, 2022
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.
Via
Benzinga
BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference
September 28, 2022
From
BioRestorative Therapies, Inc
Via
GlobeNewswire
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
September 01, 2022
By Paul Henley, Benzinga
Via
News Direct
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
September 01, 2022
In 2016, Americans spent roughly $380 billion on lower back and neck pain. In the same year, medical costs for adult obesity in the United States were $260.6 billion. That’s why BioRestorative...
Via
TheNewswire.com
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
↗
August 31, 2022
In 2016, Americans spent roughly $380 billion on lower back and neck pain. In the same year, medical costs for adult obesity in the United States were $260.6 billion.
Via
Benzinga
EXCLUSIVE: BioRestorative Therapies Adds Additional Sites For Lumbar Disc Disease Trial
↗
August 24, 2022
BioRestorative Therapies Inc (NASDAQ: BRTX) has entered into agreements with Vantage Clinical Trials LLC for its Phase 2 trial targeting chronic lumbar disc disease (cLDD).
Via
Benzinga
Giving Metabolism A Boost? BioRestorative Uses Science Surrounding Brown Fat Cells To Provide A Possible Breakthrough In Metabolic Disorders
↗
August 23, 2022
In 2017, 41.9% of Americans experienced some level of obesity. Adults experiencing obesity in 2019 spent an average of $1,861 more on medical expenses than people with a healthy weight.
Via
Benzinga
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
↗
July 27, 2022
BioRestorative Therapies Inc. (NASDAQ: BRTX), a stem cell-focused biotech, says it wants to shift the paradigm of how doctors treat chronic pain in hopes of giving patients an option that’s effective,...
Via
Benzinga
BioRestorative Shares Fall As Enrolment Initiated in Mid-Stage Chronic Back Pain Drug Study
↗
June 30, 2022
BioRestorative Therapies (NASDAQ: BRTX) enrolled first patient in the phase 2 clinical study of its lead drug BRTX-100 in chronic lumbar disc disease (cLDD).
Via
Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
↗
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
EXCLUSIVE: BioRestorative Selects Second Site For Its Lumbar Disc Disease Study
↗
June 22, 2022
BioRestorative Therapies Inc (NASDAQ: BRTX) has selected the Center for Clinical Research in North Carolina as the company's second contract for its Phase 2 trial targeting chronic lumbar disc disease...
Via
Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
↗
July 07, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
Via
Benzinga
4 Stocks Under $4 Insiders Are Aggressively Buying
↗
May 31, 2022
The Nasdaq Composite jumped around 390 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 02, 2022
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million....
Via
Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
↗
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
↗
February 01, 2022
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of...
Via
Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
↗
June 23, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 01, 2022
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 25.6% to $1.42 during Tuesday's regular session. Trading volume for Windtree Therapeutics's stock is 652.4K...
Via
Benzinga
52 Biggest Movers From Yesterday
↗
February 02, 2022
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix...
Via
Benzinga
Mid-Day Market Update: Pitney Bowes Drops After Q4 Earnings; Biofrontera Shares Climb
↗
February 01, 2022
US stocks traded mostly flat on Tuesday after recording sharp gains in the previous session. Wall Street closed the volatile January month with steep losses.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 07, 2022
Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million....
Via
Benzinga
5 Penny Stocks Insiders Are Buying
↗
January 06, 2022
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
50 Biggest Movers From Yesterday
↗
December 23, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ: ACST) jumped 52.3% to close at $1.69 on...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
December 22, 2021
Gainers BioCardia (NASDAQ:BCDA) shares ro...
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge
↗
December 22, 2021
Midway through trading Wednesday, the Dow traded up 0.41% to 35,637.05 while the NASDAQ rose 0.80% to 15,463.85. The S&P also rose, gaining 0.67% to 4,680.45. The U.S. has the...
Via
Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
↗
December 22, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United...
Via
Benzinga
Mid-Morning Market Update: Markets Edge Higher; CarMax Profit Tops Estimates
↗
December 22, 2021
Following the market opening Wednesday, the Dow traded up 0.11% to 35,530.68 while the NASDAQ rose 0.02% to 15,344.33. The S&P also rose, gaining 0.13% to 4,655.40. The U.S....
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
